Lucira Health Inc expected to post a loss of 34  cents a share - Earnings Preview

Lucira Health

12/08/2022 13:56

* Lucira Health Inc  LHDX.OQ   LHDX.O  is expected to show a
rise
in quarterly revenue when it reports  results on August 15. 
    * The Emeryville California-based  company is expected to
report 
a 141.6% increase in revenue to $30.05 million from $12.44
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lucira Health Inc
is for
a loss of 34 cents per share. For the same quarter last year,
the company reported a loss of 38 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lucira
Health Inc
is $3.5​, above​ its last closing price of $3.19. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.09       -0.08      0.40      Beat    600
 Dec. 31 2022  -0.55       -0.55      0.01      Beat    101.8
 Sep. 30 2021  -0.52       -0.51      -0.47     Beat    8.4​
 Jun. 30 2021  -0.32       -0.32      -0.38     Missed  -18.7
 ​​Mar.        -0.33       -0.33      -0.54     Missed  -63.6
 31 2021                                                
                                                        ​
 This summary was machine generated August 12 at 12:56 GMT.  All
figures in US dollars  unless otherwise stated